PatchSiren cyber security CVE debrief
CVE-2026-54214 Tobit Laboratories AG CVE debrief
The Tobit Laboratories AG TeamDavid's Webbox application is vulnerable to HTTP header injection through the 'cType' URL parameter. This allows for arbitrary modification of the Content-Type header in HTTP responses, potentially leading to open redirect attacks. The issue affects TeamDavid through Rollout 524. Security teams should assess the vulnerability's impact on their systems and implement necessary mitigations. Evidence from official CVE Program record and NIST NVD detail page supports the existence of this vulnerability. The CVE record was published on 2026-08-07T10:16:58.637Z and has not been modified since then.
- Vendor
- Tobit Laboratories AG
- Product
- TeamDavid
- CVSS
- MEDIUM 5.3
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-08-07
- Original CVE updated
- 2026-08-26
- Advisory published
- 2026-08-07
- Advisory updated
- 2026-08-26
Who should care
Security teams responsible for Tobit Laboratories AG TeamDavid's Webbox application, administrators of affected systems, security researchers interested in open redirect vulnerabilities, and operators of potentially exposed systems should be aware of this vulnerability. They should verify the 'cType' URL parameter handling, restrict control characters, and monitor for suspicious HTTP responses to prevent potential open redirect attacks.
Technical summary
The Tobit Laboratories AG TeamDavid's Webbox application is vulnerable to HTTP header injection through the 'cType' URL parameter, allowing arbitrary modification of the Content-Type header in HTTP responses. This results in an open redirect vulnerability. The issue affects TeamDavid through Rollout 524. Security teams should assess the vulnerability's impact on their systems and implement necessary mitigations.
Defensive priority
Medium-priority vulnerability with potential for open redirect attacks
Recommended defensive actions
- Verify the 'cType' URL parameter handling in Tobit Laboratories AG TeamDavid's Webbox application
- Restrict control characters in the 'cType' URL parameter
- Monitor for and block suspicious HTTP responses
- Implement additional security measures to prevent open redirect attacks
- Review compensating controls for exposed systems while remediation is scheduled and verified
- Check relevant monitoring, detection, and logs for exposed assets that need extra review
- Track exceptions, retest remediated assets, and close the item only after evidence is documented
Evidence notes
Evidence from official CVE Program record and NIST NVD detail page supports the existence of an HTTP header injection vulnerability in Tobit Laboratories AG TeamDavid's Webbox application through the 'cType' URL parameter. The vulnerability allows for arbitrary modification of the Content-Type header in HTTP responses, potentially leading to open redirect attacks. Security teams should verify the 'cType' URL parameter handling, restrict control characters, and monitor for suspicious HTTP responses. Additional security measures should be implemented to prevent open redirect attacks. Evidence limits suggest focusing on official sources and CVE details for accurate information.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-54214 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-54214
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-54214 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-54214
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://david.tobit.software/releasenotes
-
Source reference
Unverified legacy reference
URL: https://labs.infoguard.ch/posts/22-cves-in-david-a-secure-m365-alternative/
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.